On ECHEMI
Home > Drugs > Chengdu Pingyuan Pharmaceutical Co., Ltd.
Chengdu Pingyuan Pharmaceutical Co., Ltd.
  • Founded in:

    2003-09-25
  • Country:

    China China
  • Address:

    Middle section of Pingyuan Road, Qionglai City
  • Tax NO.:

    91510183752833128X
  • Registered Funds:

    30 million yuan
  • Website:

  • Email:

Related Drugs
Compound Vitamin Injection (4)
This product is a compound preparation, its components are: 2ml: contains: vitamin A 2500IU, vitamin D 2200IU, vitamin E 15mg, vitamin K 12mg.
Name Description Content CAS NO. Registered Holders
Vitamin A

It is an essential component for promoting growth, maintaining the visual function of the retina, and maintaining the stability of normal cell membranes. If it is deficient, the body will stop growing, night blindness, dry eyes, and corneal softening will occur.

More

It is an essential component for promoting growth, maintaining the visual function of the retina, and maintaining the stability of normal cell membranes. If it is deficient, the body will stop growing, night blindness, dry eyes, and corneal softening will occur.

2500IU 68-26-8 2
Vitamin D2

Form bone tissue, increase the absorption of calcium and phosphorus, and osteomalacia occurs when calcium and phosphorus are deficient

More

Form bone tissue, increase the absorption of calcium and phosphorus, and osteomalacia occurs when calcium and phosphorus are deficient

200IU 50-14-6 13
Vitamin E

Antioxidant effect of cell membrane, acting as oxygen free radical scavenger, deficiency of which causes red blood cell destruction and hemolysis, skeletal muscle and myocardial degeneration

More

Antioxidant effect of cell membrane, acting as oxygen free radical scavenger, deficiency of which causes red blood cell destruction and hemolysis, skeletal muscle and myocardial degeneration

15mg 2074-53-5 11
Vitamin K1

Can form prothrombin to maintain normal blood coagulation function. When it is deficient, it causes prothrombin deficiency bleeding.

More

Can form prothrombin to maintain normal blood coagulation function. When it is deficient, it causes prothrombin deficiency bleeding.

2mg 84-80-0 27
Ondansetron Hydrochloride Injection
Ondansetron Hydrochloride
Name Description Content CAS NO. Registered Holders
Ondansetron hydrochloride

This product is a selective 5-HT3 receptor antagonist. Its mechanism of action may be to antagonize the 5-HT3 receptors in the peripheral vagus nerve endings and central chemoreceptor areas, thereby blocking the vomiting reflex caused by factors such as chemotherapy and surgery that promote the release of 5-HT from intestinal chromaffin cells and excite the vagus afferent nerves. This product has high selectivity and no side effects such as extrapyramidal reactions and excessive sedation.

More

This product is a selective 5-HT3 receptor antagonist. Its mechanism of action may be to antagonize the 5-HT3 receptors in the peripheral vagus nerve endings and central chemoreceptor areas, thereby blocking the vomiting reflex caused by factors such as chemotherapy and surgery that promote the release of 5-HT from intestinal chromaffin cells and excite the vagus afferent nerves. This product has high selectivity and no side effects such as extrapyramidal reactions and excessive sedation.

103639-04-9 26
Pefloxacin Mesylate Injection
The main ingredient of this product is pefloxacin mesylate.
Name Description Content CAS NO. Registered Holders
Pefloxacin mesylate

Quinolone antibacterial drugs inhibit bacterial DNA helicase and have strong antibacterial activity against Enterobacter bacteria such as Escherichia coli, Klebsiella, Proteus, Shigella, Salmonella typhi, etc., as well as influenza bacillus and Neisseria. They also have certain antibacterial effects on Staphylococcus aureus and Pseudomonas aeruginosa. They have only mild effects on pneumococci, various groups of streptococci and enterococci.

More

Quinolone antibacterial drugs inhibit bacterial DNA helicase and have strong antibacterial activity against Enterobacter bacteria such as Escherichia coli, Klebsiella, Proteus, Shigella, Salmonella typhi, etc., as well as influenza bacillus and Neisseria. They also have certain antibacterial effects on Staphylococcus aureus and Pseudomonas aeruginosa. They have only mild effects on pneumococci, various groups of streptococci and enterococci.

70458-95-6 4
Acyclovir Injection
The main ingredient of this product is acyclovir, and its chemical name is: 9-[(2-hydroxyethoxy)methyl]guanine
Name Description Content CAS NO. Registered Holders
Acyclovir

This product is a synthetic nucleoside antiviral drug, which has inhibitory effects on herpes simplex virus type I (HSV-1), type H (HSV-2) and varicella-zoster virus (VZV) in vivo and in vitro. Cell culture results show that this product has the strongest inhibitory effect on HSV-1 virus, followed by HSV-2 and VZV virus. Because this product has affinity for thymidine kinase (TK) encoded by HSV and VZV, it has a highly selective inhibitory effect. This type of viral enzyme converts acyclovir into acyclovir monophosphate, a nucleoside analog. The monophosphate is further converted into diphosphate by guanylate kinase in the cell, and then converted into triphosphate by multiple enzymes in the cell. In vitro, acyclovir triphosphate stops herpes virus DNA replication.

More

This product is a synthetic nucleoside antiviral drug, which has inhibitory effects on herpes simplex virus type I (HSV-1), type H (HSV-2) and varicella-zoster virus (VZV) in vivo and in vitro. Cell culture results show that this product has the strongest inhibitory effect on HSV-1 virus, followed by HSV-2 and VZV virus. Because this product has affinity for thymidine kinase (TK) encoded by HSV and VZV, it has a highly selective inhibitory effect. This type of viral enzyme converts acyclovir into acyclovir monophosphate, a nucleoside analog. The monophosphate is further converted into diphosphate by guanylate kinase in the cell, and then converted into triphosphate by multiple enzymes in the cell. In vitro, acyclovir triphosphate stops herpes virus DNA replication.

59277-89-3 50
Ribavirin Injection
The main ingredient of this product is ribavirin, whose chemical name is 1-beta;-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide.
Name Description Content CAS NO. Registered Holders
Ribavirin

Broad-spectrum antiviral drug. It has the effect of inhibiting the growth of multiple viruses such as respiratory syncytial virus, influenza virus, hepatitis A virus, adenovirus, etc. in vitro. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase and mRNA guanosine transferase, thereby causing a decrease in intracellular guanosine triphosphate, impairing viral RNA and protein synthesis, and inhibiting viral replication and transmission. It may also have an immune effect and neutralizing antibody effect on respiratory syncytial virus.

More

Broad-spectrum antiviral drug. It has the effect of inhibiting the growth of multiple viruses such as respiratory syncytial virus, influenza virus, hepatitis A virus, adenovirus, etc. in vitro. After entering the virus-infected cells, the drug is rapidly phosphorylated, and its product acts as a competitive inhibitor of viral synthase, inhibiting inosine monophosphate dehydrogenase, influenza virus RNA polymerase and mRNA guanosine transferase, thereby causing a decrease in intracellular guanosine triphosphate, impairing viral RNA and protein synthesis, and inhibiting viral replication and transmission. It may also have an immune effect and neutralizing antibody effect on respiratory syncytial virus.

36791-04-5 33
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.